HomeInsights52 Week High Stocks

Glaxosmithkline Consumer Healthcare Ltd(merged) 52 Week High

Glaxosmithkline Consumer Healthcare Ltd(merged) 52 Week High

stocks purchased

₹ 2.7 Cr

Volume Transacted

(Apr 15, 2020)

stocks purchased

2.5 K

Stocks Traded

(Apr 15, 2020)

Last Updated on: Dec 10, 2024

Image

GlaxoSmithkline Consumer Healthcare Ltd(Merged)

NSE: GSKCONS

YEARHIGH

₹ -

Last updated on: Apr 15, 2024

Key Highlights

  • The 52 Week HIGH of GlaxoSmithkline Consumer Healthcare Ltd(Merged) is ₹ 0 as of 15 Apr 20 .

Company Fundamentals for GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

Market Price of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

1M

1Y

3Y

5Y

Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Apr 202010753.65
13 Apr 202010232.35
09 Apr 202010365.65
08 Apr 202010615.25
07 Apr 202010590.7
03 Apr 20209367.15
01 Apr 20209548.3
31 Mar 20209993.1
30 Mar 20209452.1
27 Mar 20209413.55

Asset Value vs Market Value of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical Net Profit of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

GlaxoSmithkline Consumer Healthcare Ltd(Merged) News Hub

News

Board of GlaxoSmithkline Consumer Healthcare takes on record sanction of scheme of merger

The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has ...

Read more

01 Apr 2020 12:47

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

17 Mar 2020 10:43

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

13 Jan 2020 16:32

News

GlaxoSmithkline Consumer Healthcare to announce Quarterly Result

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

15 Oct 2019 10:38

News

GlaxoSmithkline Consumer Healthcare Ltd up for third straight session

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today. The stoc...

Read more

17 Sep 2019 13:05

News

GlaxoSmithkline Consumer Healthcare Ltd gains for third straight session

GlaxoSmithkline Consumer Healthcare Ltd gained for a third straight session today. The sto...

Read more

22 Aug 2019 13:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

What is the significance of GlaxoSmithkline Consumer Healthcare Ltd(Merged) reaching its 52-week high?

GlaxoSmithkline Consumer Healthcare Ltd(Merged) reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor GlaxoSmithkline Consumer Healthcare Ltd(Merged) 52-week high?

Investors monitor GlaxoSmithkline Consumer Healthcare Ltd(Merged) 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is GlaxoSmithkline Consumer Healthcare Ltd(Merged) a good buy when it hits its 52-week high?

Whether GlaxoSmithkline Consumer Healthcare Ltd(Merged) is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important GlaxoSmithkline Consumer Healthcare Ltd(Merged) fundamentals.

What should I consider before investing in GlaxoSmithkline Consumer Healthcare Ltd(Merged) at its 52-week high?

Before investing in GlaxoSmithkline Consumer Healthcare Ltd(Merged) at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock price continue to rise after reaching its 52-week high?

GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions